Kiora Pharmaceuticals | EFFECT: Others
Mar 29 06:13 ET
Kiora Pharmaceuticals | 424B3: Prospectus
Mar 28 16:51 ET
CORRESP: CORRESP
Mar 26 12:58 ET
Kiora Pharmaceuticals | DEF 14A: Definitive information statements
Mar 25 16:35 ET
Kiora Pharmaceuticals | 8-K: Current report
Mar 25 07:08 ET
Kiora Pharmaceuticals | 10-K: Annual report
Mar 25 07:03 ET
Kiora Pharmaceuticals | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Mar 15 07:05 ET
UPLOAD: Others
Mar 4 12:58 ET
Kiora Pharmaceuticals | S-3: Registration statement for specified transactions by certain issuers
Feb 28 16:54 ET
Kiora Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lincoln Park Capital Fund, LLC(9.99%),Lincoln Park Capital, LLC(9.99%), etc.
Feb 14 17:02 ET
Kiora Pharmaceuticals | D: Filing D
Feb 14 15:54 ET
Kiora Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lind Global Fund II LP(9.9%),Lind Global Partners II LLC(9.9%), etc.
Feb 13 20:12 ET
Kiora Pharmaceuticals | 8-K: Current report
Feb 12 17:25 ET
Kiora Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals
Feb 9 16:21 ET
Kiora Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-AIGH Capital Management, LLC(9.9%),Orin H(9.9%)
Feb 7 09:26 ET
Kiora Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Mitchell P. Kopin(1.5%),Daniel B. Asher(1.5%), etc.
Feb 6 10:32 ET
Kiora Pharmaceuticals | 8-K: Current report
Feb 1 07:06 ET
Kiora Pharmaceuticals | 8-K: Current report
Jan 31 17:18 ET
Kiora Pharmaceuticals | 8-K: Current report
Jan 16 00:00 ET
Kiora Pharmaceuticals | 8-K: Current report
Nov 9, 2023 07:02 ET
No Data
No Data